HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Computational selection of RNA aptamer against angiopoietin-2 and experimental evaluation.

Abstract
Angiogenesis plays a decisive role in the growth and spread of cancer and angiopoietin-2 (Ang2) is in the spotlight of studies for its unique role in modulating angiogenesis. The aim of this study was to introduce a computational simulation approach to screen aptamers with high binding ability for Ang2. We carried out computational simulations of aptamer-protein interactions by using ZDOCK and ZRANK functions in Discovery Studio 3.5 starting from the available information of aptamers generated through the systematic evolution of ligands by exponential enrichment (SELEX) in the literature. From the best of three aptamers on the basis of ZRANK scores, 189 sequences with two-point mutations were created and simulated with Ang2. Then, we used a surface plasmon resonance (SPR) biosensor to test 3 mutant sequences of high ZRANK scores along with a high and a low affinity binding sequence as reported in the literature. We found a selected RNA aptamer has a higher binding affinity and SPR response than a reported sequence with the highest affinity. This is the first study of in silico selection of aptamers against Ang2 by using the ZRANK scoring function, which should help to increase the efficiency of selecting aptamers with high target-binding ability.
AuthorsWen-Pin Hu, Jangam Vikram Kumar, Chun-Jen Huang, Wen-Yih Chen
JournalBioMed research international (Biomed Res Int) Vol. 2015 Pg. 658712 ( 2015) ISSN: 2314-6141 [Electronic] United States
PMID25866800 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ANGPT2 protein, human
  • Angiopoietin-2
  • Aptamers, Nucleotide
Topics
  • Angiopoietin-2 (antagonists & inhibitors, chemistry)
  • Aptamers, Nucleotide (chemistry)
  • Computer Simulation
  • Humans
  • SELEX Aptamer Technique
  • Surface Plasmon Resonance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: